• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipDavos

Biden Pledges Faster U.S. Approval for Cancer Drug Cocktails

By
Reuters
Reuters
Down Arrow Button Icon
By
Reuters
Reuters
Down Arrow Button Icon
January 19, 2016, 1:50 PM ET
Preparations For The World Economic Forum (WEF) 2016
U.S. Vice President Joseph "Joe" Biden speaks during a panel session on cancer research, treatment and data science in Davos, Switzerland, on Tuesday, Jan. 19, 2016. World leaders, influential executives, bankers and policy makers attend the 46th annual meeting of the World Economic Forum in Davos from Jan. 20 - 23. Photographer: Jason Alden/Bloomberg *** Local Caption *** Joe BidenJason Alden—Bloomberg via Getty Images

DAVOS, Switzerland, Jan 19 (Reuters) – U.S. Vice President Joe Biden said on Tuesday that the United States would speed up the approval of promising new drug combinations in his government’s newly announced drive to cure cancer “once and for all.”

Biden, who lost his 46-year-old son Beau to brain cancer last year, set out his plans at a World Economic Forum meeting of international cancer experts in Davos, a week after being appointed to lead the initiative by President Barack Obama.

So-called combination therapy is increasingly seen as central to fighting tumors, as scientists unlock the different genetic factors driving cancer cell growth, but bringing such cocktails to market can be a slow and costly.

Biden said he had hosted a meeting at his home with three unnamed large drug companies and the head of the U.S. Food and Drug Administration (FDA) at which both sides had pledged to do more to get novel cancer drug cocktails to patients.

“The head of the FDA made a commitment that everybody would move much more rapidly in approving combinations,” Biden said.

At the same, the pharmaceutical industry executives had all said they were “open to different way of doing business” in order to ensure that promising drugs from different companies were tested together as early as possible, he added.

Cancer experts are particularly excited by the promise of new immunotherapy medicines that help the body’s immune system fight tumors and which have been shown to work well when used alongside other drugs.

Francis Collins, director of the U.S. National Institutes of Health, described their potential as “breath-taking.”

But such immunotherapy drugs are expensive – typically costing well over $100,000 a year per patient – and companies have traditionally been defensive about sharing early-stage medical experiments.

Obama’s call to “make America the country that cures cancer once and for all” in the last State of the Union address of his presidency has led to criticism from some scientists of an over-simplified approach to the killer condition.

The latest government-led initiative has echoes of former President Richard Nixon’s unsuccessful “War on Cancer” in the 1970s, since when scientists have discovered that cancer is hundreds of different diseases rather than one single disorder, making the notion of a single cure outdated.

Biden acknowledged the complexity in Davos.

“I’m not naive enough to think or suggest we are going to have a cure for every cancer in the world in the near term,” he said.

About the Author
By Reuters
See full bioRight Arrow Button Icon

Latest in Leadership

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Leadership

yale
PoliticsColleges and Universities
Teacher, blame thyself: Yale report savages Ivy League schools for destroying American trust in higher education
By Nick LichtenbergApril 15, 2026
2 hours ago
People protesting against tax giants.
PoliticsTaxes
How a free tax filing system from the government went from 296,000 users to zero in just one year
By Catherina GioinoApril 15, 2026
5 hours ago
Boss has lunch with her workers outside
Successcompany culture
A $24 billion Dutch lender is cutting its workforce—and to get the remaining staff on board, the CEO is having sandwiches with them
By Emma BurleighApril 15, 2026
8 hours ago
Sal Khan
SuccessEducation
This CEO has teamed up with Google, Microsoft, and McKinsey to build an AI degree that could rival Harvard—and it will cost only $10,000 to attend
By Preston ForeApril 15, 2026
8 hours ago
Why insurance giant Travelers’ CTO is placing fewer, bigger bets on AI
NewslettersCIO Intelligence
Why insurance giant Travelers’ CTO is placing fewer, bigger bets on AI
By John KellApril 15, 2026
8 hours ago
horowitz
AIdisruption
A16z’s Ben Horowitz sees ‘AI anxiety’ consuming Silicon Valley founders. Workers’ fear of something else is killing adoption
By Nick LichtenbergApril 15, 2026
8 hours ago

Most Popular

Jeff Bezos pledged $10 billion for climate change. With the 2030 clock ticking, his wife, Lauren Sánchez Bezos, is leading the charge to spend it
Environment
Jeff Bezos pledged $10 billion for climate change. With the 2030 clock ticking, his wife, Lauren Sánchez Bezos, is leading the charge to spend it
By Fortune EditorsApril 15, 2026
8 hours ago
Billionaire philanthropist MacKenzie Scott has donated again—a week after gifting millions to a college, she's just given $70 million to Meals on Wheels America
Success
Billionaire philanthropist MacKenzie Scott has donated again—a week after gifting millions to a college, she's just given $70 million to Meals on Wheels America
By Fortune EditorsApril 13, 2026
2 days ago
Palantir CEO says working at his $316 billion software company is better than a degree from Harvard or Yale: ‘No one cares about the other stuff’
Success
Palantir CEO says working at his $316 billion software company is better than a degree from Harvard or Yale: ‘No one cares about the other stuff’
By Fortune EditorsApril 14, 2026
1 day ago
Retirees are facing a $345,000 bill they never saw coming — and most aren't prepared
Commentary
Retirees are facing a $345,000 bill they never saw coming — and most aren't prepared
By Fortune EditorsApril 14, 2026
2 days ago
Warren Buffett’s first tax return showed $7 owed to the IRS. The then paperboy and former Berkshire Hathaway CEO is now worth $143 billion
Success
Warren Buffett’s first tax return showed $7 owed to the IRS. The then paperboy and former Berkshire Hathaway CEO is now worth $143 billion
By Fortune EditorsApril 14, 2026
1 day ago
Online response to the attack on Sam Altman's house shows a generational divide
Cybersecurity
Online response to the attack on Sam Altman's house shows a generational divide
By Fortune EditorsApril 14, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.